Subsequently, analysis of the expression of these genes in breast cancer and corresponding normal tissues using the UACLAN and GSCA online databases revealed that the results were consistent with those obtained by GEPIA and Kaplan Meier mapper (Supplementary Figure S2, Supplementary Figure S3), further suggesting that TP53, ACLY, JUN, and PPARG ACLY, JUN, and PPARG genes have the potential to become therapeutic candidates. This evidence concerns the gene ACLY and breast cancer.